Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Evaluation of tiquizium bromide (HSR-902), a new antispasmodic agent, as an antiulcer agent
Ist Teil von
Japanese Journal of Pharmacology, 1986, Vol.40 (suppl), p.109-109
Ort / Verlag
The Japanese Pharmacological Society
Erscheinungsjahr
1986
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
The effects of tiquizium bromide (HSR-902), a new antispasmodic agent, on the water-immersion stress ulcer, the gastric emptying, the gastric secretion and the gastric mucosal potential difference (PD) in rats were compared with those of pirenzepine dihydrochloride (Pir) and timepidium bromide (Tim). 1) HSR-902 (10 and 30 mg/kg, p.o.), Pir (10 and 30 mg/kg, p,o.) and Tim (100 mg/kg, p.o.) inhibited the water-immersion stress ulcer (23℃, 7 hr). These agents virtually did not reverse the decrease of gastric mucosal blood flow measured by the H_2 clearance method. 2) HSR-902 (10 and 30 mg/kg, p.o.) hardly influenced the gastric emptying measured by the phenol red method. Pir (30 mg/kg, p.o.), however, had a slight inhibitory effect. 3) HSR-902 (30 mg/kg) and Pir (30 mg/kg) , administered intraduodenally, inhibited the gastric secretion induced by carbachol (10 μg/kg/hr, i,v.). 4) HSR-902 (10 and 30 mg/kg, p.o.) and Pir (10 and 30 mg/kg, p.o.) inhibited the decrease of PD induced by aspirin (40 mM, 3 ml/animal, p.o.). Tim (100 mg/kg, p.o.), however, increased it. These results suggest that HSR-902 is a potent antiulcer agent without influencing the gastric emptying, and its antiulcer action may be due to antisecretory and cytoprotective activities.